A more recent study shows that Tax-transduced human hematopoietic stem cells, a preferential HTLV-1 reservoir in vivo, acquire the ability to develop CD4+ T-cell lymphomas in SCID mice [24]. The gene discussed is CNTN2; the disease is T-cell non-Hodgkin lymphoma.